CALCIUM SULFATE ANHYDROUS

CALCIUM SULFATE ANHYDROUS was reported 513 times

CALCIUM SULFATE ANHYDROUS is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 THALASSAEMIA ALPHA 1 0.0303
1 ANAL POLYP 1 0.0097
2 CELLULITIS OF MALE EXTERNAL GENITAL ORGAN 1 0.0089
3 MULTIPLE CHEMICAL SENSITIVITY 1 0.0075
4 BLOOD ALDOSTERONE INCREASED 1 0.0057
5 GINGIVAL OPERATION 1 0.0045
6 ELECTROCARDIOGRAM Q WAVE ABNORMAL 1 0.0043
7 POSTPARTUM DEPRESSION 1 0.0039
8 BREAST DISORDER FEMALE 1 0.0039
9 EYELID OPERATION 1 0.0037
10 FACIAL WASTING 1 0.0037
11 PRODUCT IMPURITY 1 0.0036
12 MUMPS 1 0.0032
13 ALLERGY TO ARTHROPOD BITE 1 0.0031
14 DECREASED VIBRATORY SENSE 1 0.0029
15 HEMIHYPOAESTHESIA 1 0.0028
16 LUNG CYST 1 0.0025
17 RAPID EYE MOVEMENTS SLEEP ABNORMAL 1 0.0024
18 TRANSFERRIN SATURATION DECREASED 1 0.0023
19 SEXUALLY INAPPROPRIATE BEHAVIOUR 1 0.0021
20 LIGAMENT PAIN 1 0.0019
21 SALIVARY GLAND ENLARGEMENT 1 0.0019
22 UTERINE INFECTION 1 0.0019
23 EYE INFECTION BACTERIAL 1 0.0018
24 COLON INJURY 1 0.0017
25 OXYGEN CONSUMPTION DECREASED 1 0.0017
26 PROLONGED LABOUR 1 0.0016
27 RECTAL FISSURE 1 0.0016
28 MAMMOGRAM ABNORMAL 1 0.0015
29 MACULAR HOLE 2 0.0015
30 KERATOACANTHOMA 1 0.0015
31 ANGULAR CHEILITIS 1 0.0014
32 PAINFUL DEFAECATION 1 0.0014
33 PEPTIC ULCER HAEMORRHAGE 1 0.0014
34 MYOFASCIAL PAIN SYNDROME 1 0.0014
35 BITE 1 0.0014
36 LIPIDS ABNORMAL 1 0.0014
37 OTITIS MEDIA ACUTE 1 0.0014
38 LEGAL PROBLEM 1 0.0014
39 OBSTRUCTIVE PANCREATITIS 1 0.0013
40 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
41 PENILE HAEMORRHAGE 1 0.0012
42 CARDIAC STRESS TEST ABNORMAL 1 0.0012
43 PERIORBITAL PAIN 1 0.0012
44 APTYALISM 1 0.0012
45 URGE INCONTINENCE 1 0.0011
46 EMOTIONAL POVERTY 2 0.0011
47 EXPOSURE VIA DIRECT CONTACT 1 0.0011
48 BENIGN BREAST NEOPLASM 1 0.0010
49 METASTASES TO PLEURA 1 0.0010
50 NAIL GROWTH ABNORMAL 1 0.0009
51 BILE DUCT CANCER 1 0.0008
52 MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0008
53 GRANULOMATOSIS WITH POLYANGIITIS 1 0.0008
54 JOINT WARMTH 1 0.0008
55 TESTICULAR SWELLING 1 0.0008
56 SINUS ARRHYTHMIA 1 0.0008
57 TONGUE DRY 1 0.0007
58 LIP BLISTER 2 0.0007
59 CLUMSINESS 2 0.0007
60 MENINGITIS BACTERIAL 1 0.0007
61 INVESTIGATION ABNORMAL 1 0.0007
62 COCCYDYNIA 1 0.0007
63 EPICONDYLITIS 1 0.0007
64 NEOPLASM SKIN 1 0.0006
65 NASAL ULCER 1 0.0006
66 FOREIGN BODY SENSATION IN EYES 4 0.0006
67 PATHOLOGICAL GAMBLING 1 0.0006
68 VEIN RUPTURE 1 0.0006
69 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
70 SENSITIVITY OF TEETH 1 0.0006
71 BREAST DISCHARGE 1 0.0006
72 EMBOLIC STROKE 2 0.0006
73 FEAR OF DISEASE 1 0.0006
74 METASTATIC RENAL CELL CARCINOMA 1 0.0005
75 DRUG DOSE TITRATION NOT PERFORMED 1 0.0005
76 INJECTION SITE CELLULITIS 1 0.0005
77 BLOOD IRON INCREASED 1 0.0005
78 LIP DISORDER 1 0.0005
79 BILE DUCT OBSTRUCTION 1 0.0005
80 SPINAL CORD COMPRESSION 2 0.0005
81 JOINT CREPITATION 1 0.0005
82 CARDIAC DISCOMFORT 1 0.0005
83 LIPIDS INCREASED 1 0.0005
84 POLYCYTHAEMIA 1 0.0005
85 CHAPPED LIPS 2 0.0005
86 REACTION TO DRUG EXCIPIENTS 1 0.0005
87 PERIARTHRITIS 1 0.0004
88 EYELID DISORDER 1 0.0004
89 NEPHROGENIC ANAEMIA 2 0.0004
90 LACUNAR INFARCTION 1 0.0004
91 GASTROINTESTINAL OBSTRUCTION 1 0.0004
92 SLOW SPEECH 1 0.0004
93 BRONCHITIS CHRONIC 1 0.0004
94 HAEMATOLOGICAL INFECTION 1 0.0004
95 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
96 CARTILAGE INJURY 1 0.0004
97 OSTEITIS 1 0.0004
98 METASTASES TO PERITONEUM 1 0.0004
99 URINARY TRACT INFECTION BACTERIAL 1 0.0004
100 ENDODONTIC PROCEDURE 1 0.0004
101 PATHOLOGICAL FRACTURE 2 0.0004
102 RETINAL DISORDER 1 0.0004
103 WHITE BLOOD CELL DISORDER 1 0.0004
104 WEIGHT BEARING DIFFICULTY 1 0.0004
105 HEART RATE ABNORMAL 2 0.0004
106 NECK MASS 1 0.0004
107 CEREBRAL THROMBOSIS 1 0.0004
108 PERONEAL NERVE PALSY 2 0.0004
109 DUODENAL ULCER HAEMORRHAGE 1 0.0003
110 HYPERTONIC BLADDER 1 0.0003
111 VOMITING PROJECTILE 1 0.0003
112 EYE PAIN 19 0.0003
113 CREPITATIONS 1 0.0003
114 CEREBROVASCULAR DISORDER 1 0.0003
115 EMERGENCY CARE 1 0.0003
116 BREAST CANCER RECURRENT 1 0.0003
117 POLYMYALGIA RHEUMATICA 1 0.0003
118 PLASMA CELL MYELOMA RECURRENT 1 0.0003
119 POSTURE ABNORMAL 1 0.0003
120 PHARYNGEAL SWELLING 3 0.0003
121 BREAST ENLARGEMENT 1 0.0003
122 SOMNAMBULISM 2 0.0003
123 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
124 VIITH NERVE PARALYSIS 1 0.0003
125 HAIR GROWTH ABNORMAL 2 0.0003
126 GRANULOMA 1 0.0003
127 TACHYPHRENIA 1 0.0003
128 LOGORRHOEA 1 0.0003
129 ASTHMATIC CRISIS 1 0.0003
130 BLOOD PHOSPHORUS DECREASED 1 0.0003
131 ALCOHOL USE 1 0.0003
132 IMPULSIVE BEHAVIOUR 1 0.0003
133 FACE INJURY 1 0.0003
134 TENDONITIS 4 0.0003
135 CONCUSSION 2 0.0003
136 SENSATION OF HEAVINESS 1 0.0003
137 EPIGASTRIC DISCOMFORT 1 0.0003
138 ORAL INFECTION 1 0.0003
139 WOUND SECRETION 1 0.0003
140 NAIL DISCOLOURATION 1 0.0003
141 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
142 FOREIGN BODY 1 0.0002
143 INTRACRANIAL ANEURYSM 1 0.0002
144 ORGAN FAILURE 1 0.0002
145 FUNGAL SKIN INFECTION 1 0.0002
146 ENURESIS 1 0.0002
147 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
148 GOITRE 1 0.0002
149 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
150 VITAMIN D DECREASED 2 0.0002
151 PRODUCT DISPENSING ISSUE 1 0.0002
152 TONGUE DISCOLOURATION 1 0.0002
153 PULMONARY FUNCTION TEST DECREASED 1 0.0002
154 ONYCHOMYCOSIS 1 0.0002
155 GROIN PAIN 2 0.0002
156 PARONYCHIA 1 0.0002
157 HAEMORRHAGIC ANAEMIA 1 0.0002
158 INJECTION SITE PAPULE 1 0.0002
159 EAR DISORDER 1 0.0002
160 INCREASED TENDENCY TO BRUISE 2 0.0002
161 GASTRITIS EROSIVE 1 0.0002
162 YELLOW SKIN 1 0.0002
163 PHOTOPHOBIA 4 0.0002
164 APHAGIA 1 0.0002
165 HUMERUS FRACTURE 1 0.0002
166 HORMONE LEVEL ABNORMAL 1 0.0002
167 NASAL POLYPS 1 0.0002
168 PANCREATIC DISORDER 1 0.0002
169 HYPERVOLAEMIA 1 0.0002
170 FLUID INTAKE REDUCED 1 0.0002
171 VEIN DISORDER 1 0.0002
172 VULVOVAGINAL PRURITUS 1 0.0002
173 HIP ARTHROPLASTY 3 0.0002
174 INITIAL INSOMNIA 2 0.0002
175 BASAL CELL CARCINOMA 3 0.0002
176 PRODUCT USE COMPLAINT 3 0.0002
177 IMPAIRED WORK ABILITY 4 0.0002
178 PRODUCT RESIDUE PRESENT 1 0.0002
179 MUSCLE TIGHTNESS 3 0.0002
180 NORMAL NEWBORN 1 0.0002
181 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
182 DEAFNESS UNILATERAL 1 0.0002
183 HYPERKERATOSIS 1 0.0002
184 NERVE INJURY 2 0.0002
185 PERIORBITAL SWELLING 1 0.0002
186 DERMATITIS CONTACT 2 0.0002
187 MICTURITION URGENCY 2 0.0002
188 EXERCISE TOLERANCE DECREASED 1 0.0002
189 PRODUCT SUBSTITUTION ISSUE 10 0.0002
190 SPINAL PAIN 2 0.0002
191 URINE ODOUR ABNORMAL 1 0.0002
192 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
193 LYMPHOCYTE COUNT DECREASED 3 0.0002
194 ENERGY INCREASED 1 0.0002
195 CATARACT OPERATION 1 0.0002
196 THIRST 3 0.0002
197 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
198 NOCTURIA 2 0.0002
199 SPINAL OPERATION 2 0.0002
200 TENDON RUPTURE 2 0.0002
201 GENERALISED OEDEMA 2 0.0002
202 SCREAMING 1 0.0002
203 PROCTALGIA 1 0.0002
204 HAEMOGLOBIN ABNORMAL 1 0.0002
205 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1 0.0002
206 JOINT STIFFNESS 4 0.0002
207 HYPOGAMMAGLOBULINAEMIA 1 0.0002
208 SKIN MASS 1 0.0001
209 QUALITY OF LIFE DECREASED 2 0.0001
210 PRODUCT LABEL ISSUE 1 0.0001
211 MATERNAL EXPOSURE BEFORE PREGNANCY 1 0.0001
212 BLOOD TESTOSTERONE DECREASED 1 0.0001
213 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
214 ONYCHOCLASIS 1 0.0001
215 DROOLING 1 0.0001
216 LYMPHOEDEMA 1 0.0001
217 COORDINATION ABNORMAL 2 0.0001
218 BLOOD TEST ABNORMAL 2 0.0001
219 PULMONARY TOXICITY 1 0.0001
220 VISUAL FIELD DEFECT 1 0.0001
221 RASH PUSTULAR 1 0.0001
222 DYSSTASIA 4 0.0001
223 THERAPY CESSATION 7 0.0001
224 LABORATORY TEST ABNORMAL 4 0.0001
225 CEREBRAL DISORDER 1 0.0001
226 SKIN HAEMORRHAGE 2 0.0001
227 ARTHROPOD BITE 1 0.0001
228 TOOTH DISORDER 3 0.0001
229 COLON CANCER 2 0.0001
230 HEART RATE IRREGULAR 3 0.0001
231 LACRIMATION INCREASED 4 0.0001
232 TENDON PAIN 1 0.0001
233 BLOOD COUNT ABNORMAL 2 0.0001
234 BOWEL MOVEMENT IRREGULARITY 1 0.0001
235 DISSOCIATION 1 0.0001
236 MUSCLE TWITCHING 3 0.0001
237 APHTHOUS ULCER 1 0.0001
238 GASTROINTESTINAL INFLAMMATION 1 0.0001
239 DRUG SCREEN POSITIVE 1 0.0001
240 FURUNCLE 1 0.0001
241 RENAL CYST 1 0.0001
242 BLOOD DISORDER 1 0.0001
243 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
244 FRUSTRATION TOLERANCE DECREASED 1 0.0001
245 MUSCLE DISORDER 1 0.0001
246 BLOOD POTASSIUM INCREASED 2 0.0001
247 POST PROCEDURAL INFECTION 1 0.0001
248 PRODUCT DOSE OMISSION 8 0.0001
249 ASPHYXIA 1 0.0001
250 POLYURIA 1 0.0001
251 ABNORMAL FAECES 1 0.0001
252 EYE IRRITATION 7 0.0001
253 ESCHERICHIA INFECTION 1 0.0001
254 PHOTOSENSITIVITY REACTION 2 0.0001
255 VIRAL INFECTION 4 0.0001
256 BLOOD UREA INCREASED 2 0.0001
257 ANGER 4 0.0001
258 FLUSHING 12 0.0001
259 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
260 URINE OUTPUT DECREASED 1 0.0001
261 COLD SWEAT 2 0.0001
262 GOUT 2 0.0001
263 PAIN OF SKIN 3 0.0001
264 END STAGE RENAL DISEASE 2 0.0001
265 NERVE COMPRESSION 1 0.0001
266 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
267 PERSONALITY CHANGE 1 0.0001
268 MIDDLE INSOMNIA 2 0.0001
269 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
270 PRODUCT PACKAGING ISSUE 1 0.0001
271 INTENTIONAL DOSE OMISSION 3 0.0001
272 MIGRAINE 10 0.0001
273 BALANCE DISORDER 9 0.0001
274 PRESCRIBED OVERDOSE 2 0.0001
275 PLASMA CELL MYELOMA 4 0.0001
276 SKIN FISSURES 2 0.0001
277 THERAPY CHANGE 1 0.0001
278 HOSPICE CARE 1 0.0001
279 LIGAMENT SPRAIN 1 0.0001
280 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
281 EMBEDDED DEVICE 1 0.0001
282 BLADDER DISORDER 1 0.0001
283 SALIVARY HYPERSECRETION 1 0.0001
284 APHASIA 3 0.0001
285 EMPHYSEMA 1 0.0001
286 TOOTH ABSCESS 1 0.0001
287 BLINDNESS 4 0.0001
288 RIB FRACTURE 2 0.0001
289 TEMPERATURE INTOLERANCE 1 0.0001
290 VENTRICULAR EXTRASYSTOLES 1 0.0001
291 POLLAKIURIA 4 0.0001
292 KNEE ARTHROPLASTY 2 0.0001
293 SCRATCH 1 0.0001
294 NEUROPATHY PERIPHERAL 9 0.0001
295 INCONTINENCE 1 0.0001
296 FULL BLOOD COUNT ABNORMAL 1 0.0001
297 RENAL PAIN 1 0.0001
298 MOOD SWINGS 3 0.0001
299 BREAST PAIN 1 0.0001
300 EPISTAXIS 7 0.0001
301 HEREDITARY ANGIOEDEMA 1 0.0001
302 BREAST CANCER METASTATIC 1 0.0001
303 HOT FLUSH 7 0.0001
304 MUSCLE SPASMS 17 0.0001
305 PRURITUS GENERALISED 2 0.0001
306 BLOOD PRESSURE INCREASED 14 0.0001
307 TOOTH FRACTURE 1 0.0001
308 FUNGAL INFECTION 3 0.0001
309 HYPERTENSIVE CRISIS 1 0.0001
310 GLOSSODYNIA 2 0.0001
311 OCULAR DISCOMFORT 1 0.0001
312 PARAESTHESIA 14 0.0001
313 BLOOD CALCIUM DECREASED 1 0.0001
314 GAIT DISTURBANCE 17 0.0001
315 IMPAIRED DRIVING ABILITY 1 0.0001
316 CHOLECYSTECTOMY 1 0.0001
317 INTERNAL HAEMORRHAGE 1 0.0001
318 HYPOAESTHESIA 13 0.0001
319 RENAL DISORDER 4 0.0001
320 BURNING SENSATION 6 0.0001
321 BLOOD IRON DECREASED 1 0.0001
322 CATARACT 5 0.0001
323 MACULAR DEGENERATION 1 0.0001
324 MUSCLE RIGIDITY 1 0.0001
325 WRIST FRACTURE 1 0.0001
326 LOCALISED INFECTION 2 0.0001
327 ABDOMINAL PAIN UPPER 17 0.0001
328 CRYING 3 0.0001
329 VERTIGO 5 0.0001
330 RESTLESSNESS 3 0.0001
331 FEELING HOT 5 0.0001
332 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
333 HYPERCALCAEMIA 1 0.0001
334 ABASIA 2 0.0001
335 EYE SWELLING 3 0.0001
336 HAIR COLOUR CHANGES 1 0.0001
337 AGEUSIA 2 0.0001
338 VISION BLURRED 11 0.0001
339 INJECTION SITE DISCOLOURATION 1 0.0001
340 INTENTIONAL PRODUCT MISUSE 7 0.0001
341 CHRONIC KIDNEY DISEASE 6 0.0001
342 MUSCLE ATROPHY 1 0.0001
343 PRODUCT COMPLAINT 2 0.0001
344 FLUID RETENTION 4 0.0001
345 INTRAOCULAR PRESSURE INCREASED 1 0.0001
346 SKIN ULCER 2 0.0001
347 RASH GENERALISED 2 0.0001
348 IMMUNE SYSTEM DISORDER 1 0.0001
349 TOOTH INFECTION 1 0.0001
350 PULMONARY CONGESTION 1 0.0001
351 HAIR TEXTURE ABNORMAL 1 0.0001
352 FEAR 2 0.0001
353 THROAT TIGHTNESS 2 0.0001
354 PRODUCT TASTE ABNORMAL 1 0.0001
355 DRUG TOXICITY 1 0.0001
356 GINGIVAL BLEEDING 1 0.0001
357 PERIPHERAL COLDNESS 1 0.0001
358 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
359 CONTUSION 7 0.0001
360 ABNORMAL DREAMS 2 0.0001
361 ORAL DISCOMFORT 1 0.0001
362 NECK PAIN 4 0.0001
363 CARPAL TUNNEL SYNDROME 1 0.0001
364 ALOPECIA 14 0.0001
365 PAIN IN EXTREMITY 21 0.0001
366 DYSPEPSIA 7 0.0001
367 LYMPHOPENIA 1 0.0001
368 DEPRESSION 16 0.0001
369 MYELODYSPLASTIC SYNDROME 1 0.0001
370 ANOSMIA 1 0.0001
371 CONSTIPATION 15 0.0001
372 APATHY 1 0.0001
373 PALPITATIONS 8 0.0001
374 SURGERY 4 0.0001
375 CONFUSIONAL STATE 11 0.0001
376 ILLNESS 7 0.0001
377 LIVER DISORDER 3 0.0001
378 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
379 GASTROINTESTINAL DISORDER 6 0.0001
380 BLOOD POTASSIUM DECREASED 2 0.0001
381 HYPOAESTHESIA ORAL 1 0.0001
382 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
383 DRUG DISPENSING ERROR 1 0.0001
384 PHARYNGEAL OEDEMA 1 0.0001
385 PERIPHERAL SWELLING 10 0.0001
386 THYROID DISORDER 1 0.0001
387 OROPHARYNGEAL PAIN 6 0.0001
388 MUSCULOSKELETAL CHEST PAIN 1 0.0001
389 EJECTION FRACTION DECREASED 1 0.0001
390 COGNITIVE DISORDER 3 0.0001
391 SWOLLEN TONGUE 2 0.0001
392 ARTHRITIS 5 0.0001
393 OCULAR HYPERAEMIA 3 0.0001
394 COMA 3 0.0001
395 MULTIPLE SCLEROSIS 3 0.0001
396 SCIATICA 1 0.0001
397 ABSCESS 1 0.0001
398 FEELING ABNORMAL 15 0.0001
399 ARTHRALGIA 26 0.0001
400 WEIGHT INCREASED 14 0.0001
401 DRUG INTOLERANCE 6 0.0001
402 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
403 NIGHT SWEATS 2 0.0001
404 BACK DISORDER 1 0.0001
405 AMNESIA 4 0.0001
406 METASTASES TO BONE 1 0.0001
407 INFLUENZA LIKE ILLNESS 5 0.0001
408 TREMOR 10 0.0001
409 DRY EYE 3 0.0001
410 INSOMNIA 16 0.0001
411 SKIN DISORDER 2 0.0001
412 AGGRESSION 3 0.0001
413 CHILLS 7 0.0001
414 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
415 SKIN EXFOLIATION 5 0.0001
416 HEMIPARESIS 1 0.0001
417 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
418 METRORRHAGIA 1 0.0001
419 MUSCULOSKELETAL DISCOMFORT 1 0.0001
420 MULTI-ORGAN FAILURE 1 0.0001
421 NIGHTMARE 2 0.0001
422 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
423 SPEECH DISORDER 3 0.0001
424 DEVICE USE ISSUE 1 0.0001
425 MUSCULOSKELETAL STIFFNESS 5 0.0001
426 AMENORRHOEA 1 0.0001
427 PAIN 35 0.0001
428 HEART RATE DECREASED 2 0.0001
429 SLEEP DISORDER 4 0.0001
430 VISUAL IMPAIRMENT 7 0.0001
431 HEAD DISCOMFORT 1 0.0001
432 MOBILITY DECREASED 4 0.0001
433 DISTURBANCE IN ATTENTION 3 0.0001
434 TOOTHACHE 1 0.0001
435 OSTEOMYELITIS 1 0.0001
436 RESTLESS LEGS SYNDROME 1 0.0001
437 BONE DISORDER 1 0.0001
438 PANIC ATTACK 2 0.0001
439 SUICIDAL IDEATION 5 0.0001
440 PRODUCT DOSE OMISSION ISSUE 16 0.0001
441 BLOOD GLUCOSE ABNORMAL 1 0.0001
442 FALL 18 0.0001
443 ARTHROPATHY 3 0.0001
444 CONJUNCTIVITIS 1 0.0001
445 DYSGEUSIA 4 0.0001
446 HEPATIC STEATOSIS 1 0.0001
447 THINKING ABNORMAL 1 0.0001
448 BLISTER 3 0.0001
449 BLOOD SODIUM DECREASED 1 0.0001
450 FOOT FRACTURE 1 0.0001
451 BLOOD URINE PRESENT 1 0.0001
452 HEADACHE 33 0.0001
453 MUSCULOSKELETAL DISORDER 1 0.0001
454 FEELING JITTERY 1 0.0001
455 SLEEP APNOEA SYNDROME 1 0.0001
456 LETHARGY 3 0.0001
457 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
458 SEIZURE 6 0.0001
459 GLAUCOMA 1 0.0001
460 ERUCTATION 1 0.0001
461 DYSTONIA 1 0.0001
462 DIARRHOEA 33 0.0001
463 NASAL CONGESTION 3 0.0001
464 MEMORY IMPAIRMENT 7 0.0001
465 UPPER LIMB FRACTURE 1 0.0001
466 WEIGHT DECREASED 14 0.0001
467 DIZZINESS 25 0.0001
468 THROMBOSIS 4 0.0000
469 JOINT SWELLING 6 0.0000
470 FULL BLOOD COUNT DECREASED 1 0.0000
471 PRODUCT PHYSICAL ISSUE 1 0.0000
472 STOMATITIS 3 0.0000
473 EXTRA DOSE ADMINISTERED 2 0.0000
474 PSORIATIC ARTHROPATHY 2 0.0000
475 DISCOMFORT 3 0.0000
476 OSTEOPOROSIS 2 0.0000
477 INJECTION SITE WARMTH 1 0.0000
478 TOOTH LOSS 1 0.0000
479 PULMONARY HYPERTENSION 1 0.0000
480 ASTHENIA 18 0.0000
481 HAEMORRHAGE 5 0.0000
482 URTICARIA 8 0.0000
483 OSTEOARTHRITIS 2 0.0000
484 EATING DISORDER 1 0.0000
485 RETCHING 1 0.0000
486 RECTAL HAEMORRHAGE 2 0.0000
487 HYPOACUSIS 2 0.0000
488 POOR QUALITY SLEEP 1 0.0000
489 MENTAL DISORDER 2 0.0000
490 PRODUCT PRESCRIBING ISSUE 1 0.0000
491 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
492 MELAENA 1 0.0000
493 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
494 THROAT IRRITATION 2 0.0000
495 ADVERSE DRUG REACTION 4 0.0000
496 CHROMATURIA 1 0.0000
497 SKIN IRRITATION 2 0.0000
498 TINNITUS 2 0.0000
499 SHOCK 1 0.0000
500 PERICARDIAL EFFUSION 1 0.0000
501 PNEUMONIA 14 0.0000
502 DECREASED APPETITE 10 0.0000
503 BACK PAIN 10 0.0000
504 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
505 SWELLING 4 0.0000
506 DRUG DOSE OMISSION 7 0.0000
507 DYSPHAGIA 4 0.0000
508 DISEASE RECURRENCE 2 0.0000
509 RASH ERYTHEMATOUS 2 0.0000
510 ABDOMINAL DISCOMFORT 7 0.0000
511 HEPATIC CANCER 1 0.0000
512 INTERSTITIAL LUNG DISEASE 2 0.0000
513 MENTAL IMPAIRMENT 1 0.0000
514 FIBROMYALGIA 1 0.0000
515 AGITATION 3 0.0000
516 LUNG DISORDER 2 0.0000
517 INJECTION SITE URTICARIA 1 0.0000
518 OSTEONECROSIS OF JAW 1 0.0000
519 HEART RATE INCREASED 4 0.0000
520 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
521 COVID-19 7 0.0000
522 HALLUCINATION 3 0.0000
523 ACNE 3 0.0000
524 ABDOMINAL PAIN LOWER 1 0.0000
525 CHEST DISCOMFORT 4 0.0000
526 PRURITUS 15 0.0000
527 DIPLOPIA 1 0.0000
528 RESPIRATORY TRACT INFECTION 1 0.0000
529 NERVOUSNESS 2 0.0000
530 DEAFNESS 1 0.0000
531 MUSCULOSKELETAL PAIN 2 0.0000
532 DEPRESSED MOOD 2 0.0000
533 CHEST PAIN 7 0.0000
534 INJECTION SITE BRUISING 3 0.0000
535 EAR INFECTION 1 0.0000
536 DEHYDRATION 5 0.0000
537 BREAST CANCER FEMALE 1 0.0000
538 CARDIAC FAILURE CONGESTIVE 3 0.0000
539 FATIGUE 29 0.0000
540 FREQUENT BOWEL MOVEMENTS 1 0.0000
541 DRY MOUTH 3 0.0000
542 RASH PRURITIC 2 0.0000
543 OEDEMA 2 0.0000
544 LIMB INJURY 1 0.0000
545 MALAISE 16 0.0000
546 RESPIRATORY DISTRESS 1 0.0000
547 DIVERTICULITIS 1 0.0000
548 FEELING COLD 1 0.0000
549 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
550 INFLUENZA 4 0.0000
551 HAEMOPTYSIS 1 0.0000
552 DEMENTIA 1 0.0000
553 WOUND 1 0.0000
554 NAUSEA 28 0.0000
555 PAIN IN JAW 1 0.0000
556 MYALGIA 6 0.0000
557 MUSCULAR WEAKNESS 4 0.0000
558 HYPERSOMNIA 1 0.0000
559 PANCREATIC CARCINOMA 1 0.0000
560 DYSPHONIA 2 0.0000
561 BONE PAIN 2 0.0000
562 ACUTE MYOCARDIAL INFARCTION 1 0.0000
563 URINARY INCONTINENCE 1 0.0000
564 HEPATIC FAILURE 1 0.0000
565 SUICIDE ATTEMPT 2 0.0000
566 ILL-DEFINED DISORDER 2 0.0000
567 PLEURAL EFFUSION 2 0.0000
568 EPILEPSY 1 0.0000
569 ACUTE KIDNEY INJURY 5 0.0000
570 DRUG ADMINISTRATION ERROR 1 0.0000
571 ADVERSE EVENT 3 0.0000
572 NASOPHARYNGITIS 6 0.0000
573 HOSPITALISATION 5 0.0000
574 EMOTIONAL DISORDER 1 0.0000
575 HYPERSENSITIVITY 6 0.0000
576 LIMB DISCOMFORT 1 0.0000
577 FEMUR FRACTURE 1 0.0000
578 NERVOUS SYSTEM DISORDER 1 0.0000
579 PRODUCT USE ISSUE 6 0.0000
580 BLOOD GLUCOSE INCREASED 6 0.0000
581 ANXIETY 9 0.0000
582 CYSTITIS 1 0.0000
583 HYPOTHYROIDISM 1 0.0000
584 LOSS OF CONSCIOUSNESS 4 0.0000
585 MOVEMENT DISORDER 1 0.0000
586 HIP FRACTURE 1 0.0000
587 RHINORRHOEA 2 0.0000
588 ATRIAL FIBRILLATION 3 0.0000
589 DEEP VEIN THROMBOSIS 2 0.0000
590 PSORIASIS 4 0.0000
591 IMPAIRED HEALING 1 0.0000
592 EYE DISORDER 1 0.0000
593 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
594 RENAL FAILURE 4 0.0000
595 VISUAL ACUITY REDUCED 1 0.0000
596 EXPIRED PRODUCT ADMINISTERED 1 0.0000
597 DYSPNOEA 17 0.0000
598 LIP SWELLING 1 0.0000
599 URINARY RETENTION 1 0.0000
600 GAIT INABILITY 1 0.0000
601 RASH 13 0.0000
602 SOMNOLENCE 6 0.0000
603 VOMITING 14 0.0000
604 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
605 CONDITION AGGRAVATED 9 0.0000
606 PRODUCT QUALITY ISSUE 4 0.0000
607 HEPATIC ENZYME INCREASED 2 0.0000
608 URINARY TRACT INFECTION 5 0.0000
609 SINUSITIS 3 0.0000
610 HAEMATURIA 1 0.0000
611 GASTRIC DISORDER 1 0.0000
612 DELIRIUM 1 0.0000
613 MYOCARDIAL INFARCTION 5 0.0000
614 HYPERKALAEMIA 1 0.0000
615 LYMPHADENOPATHY 1 0.0000
616 PLATELET COUNT DECREASED 3 0.0000
617 THERAPY INTERRUPTED 2 0.0000
618 CEREBRAL HAEMORRHAGE 1 0.0000
619 INFECTION 4 0.0000
620 HYPERGLYCAEMIA 1 0.0000
621 UNDERDOSE 2 0.0000
622 ACCIDENTAL OVERDOSE 1 0.0000
623 DYSURIA 1 0.0000
624 INJECTION SITE MASS 1 0.0000
625 DYSARTHRIA 1 0.0000
626 DYSPNOEA EXERTIONAL 1 0.0000
627 ASTHMA 3 0.0000
628 INTESTINAL OBSTRUCTION 1 0.0000
629 COLITIS 1 0.0000
630 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
631 ABNORMAL BEHAVIOUR 1 0.0000
632 DISORIENTATION 1 0.0000
633 OEDEMA PERIPHERAL 3 0.0000
634 DYSKINESIA 1 0.0000
635 NEUTROPHIL COUNT DECREASED 1 0.0000
636 LUNG NEOPLASM MALIGNANT 1 0.0000
637 RHABDOMYOLYSIS 1 0.0000
638 WITHDRAWAL SYNDROME 1 0.0000
639 CEREBROVASCULAR ACCIDENT 4 0.0000
640 RENAL FAILURE ACUTE 1 0.0000
641 DEVICE DISLOCATION 1 0.0000
642 SEPTIC SHOCK 1 0.0000
643 ANGIOEDEMA 1 0.0000
644 TACHYCARDIA 2 0.0000
645 DRY SKIN 3 0.0000
646 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
647 DEVICE ISSUE 2 0.0000
648 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
649 SKIN DISCOLOURATION 1 0.0000
650 HYPOKALAEMIA 1 0.0000
651 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
652 COUGH 6 0.0000
653 CARDIAC DISORDER 2 0.0000
654 COLORECTAL CANCER 1 0.0000
655 PRODUCTIVE COUGH 1 0.0000
656 BLOOD GLUCOSE DECREASED 1 0.0000
657 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
658 CELLULITIS 1 0.0000
659 PANCREATITIS 1 0.0000
660 BRADYCARDIA 1 0.0000
661 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
662 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
663 HAEMATOCHEZIA 1 0.0000
664 SEPSIS 2 0.0000
665 FLATULENCE 1 0.0000
666 RHEUMATOID ARTHRITIS 2 0.0000
667 DEATH 15 0.0000
668 HERPES ZOSTER 1 0.0000
669 PYREXIA 6 0.0000
670 ABDOMINAL PAIN 4 0.0000
671 DISEASE PROGRESSION 2 0.0000
672 IRRITABILITY 1 0.0000
673 THERAPEUTIC RESPONSE DECREASED 1 0.0000
674 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
675 INJECTION SITE ERYTHEMA 2 0.0000
676 ANAEMIA 3 0.0000
677 HYPERHIDROSIS 2 0.0000
678 SWELLING FACE 1 0.0000
679 BLOOD PRESSURE DECREASED 1 0.0000
680 NEOPLASM MALIGNANT 1 0.0000
681 HYPOTENSION 3 0.0000
682 INJECTION SITE PRURITUS 1 0.0000
683 INJECTION SITE REACTION 1 0.0000
684 DEVICE MALFUNCTION 1 0.0000
685 HYPERTENSION 3 0.0000
686 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
687 SKIN BURNING SENSATION 1 0.0000
688 BRONCHITIS 1 0.0000
689 DIABETES MELLITUS 1 0.0000
690 DRUG INTERACTION 2 0.0000
691 CARDIAC FAILURE 1 0.0000
692 PROSTATE CANCER 1 0.0000
693 DRUG INEFFECTIVE 16 0.0000
694 CARDIAC ARREST 1 0.0000
695 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
696 OFF LABEL USE 10 0.0000
697 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
698 DRUG WITHDRAWAL SYNDROME 1 0.0000
699 BREAST CANCER 1 0.0000
700 PULMONARY EMBOLISM 1 0.0000
701 SYNCOPE 1 0.0000
702 ERYTHEMA 2 0.0000
703 ABDOMINAL DISTENSION 1 0.0000
704 OVERDOSE 2 0.0000
705 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
706 INCORRECT DOSE ADMINISTERED 2 0.0000
707 NEUTROPENIA 1 0.0000
708 TOXICITY TO VARIOUS AGENTS 1 0.0000
709 NO ADVERSE EVENT 1 0.0000
710 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
711 INJECTION SITE PAIN 1 0.0000